Literature DB >> 23300193

Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing.

Hung-Fat Tse1, Jenny C Y Ho, Shing-Wan Choi, Yee-Ki Lee, Amy W Butler, Kwong-Man Ng, Chung-Wah Siu, Michael A Simpson, Wing-Hon Lai, Yau-Chi Chan, Ka-Wing Au, Jinqiu Zhang, Kenneth W J Lay, Miguel A Esteban, John M Nicholls, Alan Colman, Pak C Sham.   

Abstract

In this paper, we report a novel heterozygous mutation of A285V codon conversion on exon 4 of the desmin (DES), using whole exome sequencing (WES) in an isolated proband with documented dilated cardiomyopathy (DCM). This mutation is predicted to cause three-dimensional structure changes of DES. Immunohistological and electron microscopy studies demonstrated diffuse abnormal DES aggregations in DCM-induced-pluripotent stem cell (iPSC)-derived cardiomyocytes, and control-iPSC-derived cardiomyocytes transduced with A285V-DES. DCM-iPSC-derived cardiomyocytes also exhibited functional abnormalities in vitro. This is the first demonstration that patient-specific iPSC-derived cardiomyocytes can be used to provide histological and functional confirmation of a suspected genetic basis for DCM identified by WES.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23300193     DOI: 10.1093/hmg/dds556

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  48 in total

Review 1.  Genetic testing for inherited cardiac disease.

Authors:  Arthur A M Wilde; Elijah R Behr
Journal:  Nat Rev Cardiol       Date:  2013-07-30       Impact factor: 32.419

Review 2.  Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.

Authors:  Forum Kamdar; Andre Klaassen Kamdar; Naoko Koyano-Nakagawa; Mary G Garry; Daniel J Garry
Journal:  J Card Fail       Date:  2015-04-28       Impact factor: 5.712

Review 3.  Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.

Authors:  Jan W Buikema; Sean M Wu
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

Review 4.  Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes.

Authors:  Patrizia Dell'Era; Patrizia Benzoni; Elisabetta Crescini; Matteo Valle; Er Xia; Antonella Consiglio; Maurizio Memo
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 5.  The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.

Authors:  Lingqun Ye; Xuan Ni; Zhen-Ao Zhao; Wei Lei; Shijun Hu
Journal:  J Cardiovasc Transl Res       Date:  2018-05-29       Impact factor: 4.132

Review 6.  Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery.

Authors:  Katherine A Campbell; Andre Terzic; Timothy J Nelson
Journal:  Regen Med       Date:  2015-10-06       Impact factor: 3.806

Review 7.  Molecular insights into cardiomyopathies associated with desmin (DES) mutations.

Authors:  Andreas Brodehl; Anna Gaertner-Rommel; Hendrik Milting
Journal:  Biophys Rev       Date:  2018-06-20

Review 8.  Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.

Authors:  Nazish Sayed; Chun Liu; Joseph C Wu
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

Review 9.  Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.

Authors:  Kiran Musunuru; Farah Sheikh; Rajat M Gupta; Steven R Houser; Kevin O Maher; David J Milan; Andre Terzic; Joseph C Wu
Journal:  Circ Genom Precis Med       Date:  2018-01-12

Review 10.  Human-induced pluripotent stem cell models of inherited cardiomyopathies.

Authors:  Ioannis Karakikes; Vittavat Termglinchan; Joseph C Wu
Journal:  Curr Opin Cardiol       Date:  2014-05       Impact factor: 2.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.